Earlier, BioNews Texas reported on how seven researchers from Texas A&M were selected as this year’s Fellows by the American Association for the Advancement of Science (AAAS). Now, MD Anderson has announced that it too has contributed to the 2013-2014 class of AAAS Fellows with four researchers of its own.
According to a press release from the MD Anderson newsroom, the four researchers include “a basic scientist, a biostatistician and two researchers who connect scientific findings with the clinic” — diverse roles within MD Anderson that, like the Texas A&M Fellows, demonstrate how Texas research universities are leading in a wide range of different specialities and disciplines. MD Anderson President Ronald DePinho, M.D., echoed this sentiment in remarks of his own, stating, “Election to AAAS is richly deserved, elite peer recognition for our four new fellows, who reflect the multidisciplinary excellence of MD Anderson faculty.”
Counting the 4 new awardees this year, MD Anderson now boasts 23 AAAS Fellows on its faculty, 14 of which were elected in just the last three years. The 2013-2014 Fellows include:
- Michael Andreeff, M.D., Ph.D., professor of Leukemia and chief of Section of Molecular Hematology and Therapy, for landmark contributions in translating knowledge of cancer-fighting apoptotic (cell suicide) mechanisms in acute myelogenous leukemia to the development of novel therapies using BH3 mimics, and the targeting of apoptosis inhibitors MDM2 and ARC.
- Ethan Dmitrovsky, M.D., provost and executive vice president, for distinguished contributions to the establishment of retinoid differentiation therapy for acute promyelocytic leukemia (APL), cloning its genetic rearrangement, developing a molecular test for it, and finding a mechanism that degrades the fusion protein that causes the disease.
- Kim-Anh Do, Ph.D., professor and chair of Biostatistics, for distinguished contributions to computational statistics and integrated statistical methodology to analyze complex genetic, protein and metabolic data, with applications to translational cancer research and personalized medicine.
- Richard D. Wood, Ph.D., professor of Molecular Carcinogenesis, for pioneering and fundamental discoveries regarding mechanisms of DNA nucleotide excision repair and the role of specialized DNA polymerases, enzymes used to copy DNA, in minimizing genome instability and cancer.
Of particular note is Dr. Ethan Dmitrovsky, who has made headlines several times on BioNews Texas, including last month, when he was named a member of the Institute of Medicine (IOM) of the National Academies. “Honors such as this only come through the efforts and dedication of many others over many years,” Dmitrovsky said. “Working with my research team and other collaborators is a privilege.”